Global Sterile and Antiviral Packaging Market– Industry Trends and Forecast to 2029

Global Sterile and Antiviral Packaging Market, By Packaging Type (Vials and Ampoules, Blister and Clamshells), Material Type ((Plastics, Glass, Metal, Paper and Paperboard), End-User (Surgical and Medical Instruments, Pharmaceuticals and Biological) – Industry Trends and Forecast to 2029.

Sterile and Antiviral Packaging Market Analysis and Size

Consumer behavior has drastically evolved over time. The demand for packaging solutions that are sterile, antiviral, and contamination-free is increasing quickly on a global scale due to various regulations. According to the Centers for Disease Control and Prevention's (CDC) "The Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008", the patient-care medical devices should be completely cleaned, disinfected, and sterilized by the suggested procedures. The consumers' concerns about hygiene have increased as a result of COVID-19. Additionally, given their antibacterial qualities, sterile and antiviral packaging is in higher demand due to the SARS-CoV-2 virus's capacity to survive longer on surfaces. Many businesses, from food and beverage to medicines, are investing in cutting-edge packaging solutions as consumers become more and more health-conscious, thus boosting the overall growth rate for the market.

Global sterile and antiviral packaging market was valued at USD 24.07 billion in 2021 and is expected to reach USD 40.44 billion by 2029, registering a CAGR of 6.70% during the forecast period of 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, patent analysis and technological advancements.

Sterile and Antiviral Packaging Market Scope and Segmentation

Market Definition

Sterile and antiviral packaging is basically a form of packing procedure that maintains and shields a product from harm or contamination. Syringes and pill containers must be processed in facilities free of hazardous particle matter in the medical and pharmaceutical industries. Additionally, some delicate products need to be packaged in sterile containers to protect them from air and packaging solution reactions. The most popular sterile and antiviral packaging choices are often blister packaging, safe-edge trays, surgical trays, and custom thermoform designs.

Sterile and Antiviral Packaging Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

• Growth In Geriatric Population

According to the U.S. Census Bureau, by 2060, the elderly population in U.S. is predicted to double up, making up around 25% of the overall population. The same situation has been observed in other regions of the world, where older individuals make up approximately a third of all healthcare spending. The delivery of oral medication to the elderly population is accompanied with a number of challenges. Parenteral medication delivery is the most effective treatment for them. A significant factor in the demand for medical equipment and other disposable supplies, as well as for sterile and antiviral packaging, is the ageing population, which is fueled by a dropping birth rate and rising life expectancy. As a result, the increment in geriatric population further boosts the demand for the sterile and antiviral packaging, thus boosting the market growth rate over the forecast period.

• Surge in Combination Drug Products and Biologics Usage

The use of biologics in treating chronic diseases like diabetes and arthritis has grown significantly in popularity. As these are protein components taken from live creatures, the manufacturing procedure is extremely complicated and calls for stability. Therefore, maintaining and preserving biologics calls for a high level of competence. Manufacturers of biologics are now in great demand for inventive product packaging as a result of this. This is then anticipated to increase demand for biologics packaging materials globally. To meet the needs of the biologics market, packaging companies have introduced a variety of container closure technologies, thus accelerating the overall growth rate for the market.

Furthermore, the widespread utilization of these packaging across the various end use industries will further propel the growth rate of sterile and antiviral packaging market.  The rise in demand for single-use medical equipment and the increased demand for sterile packaging systems will drive market value growth. The escalation in demand of disposable devices and the surge in healthcare awareness about sterile medical supplies are other market growth determinants.

Opportunities

• Product Innovations and Awareness

The various product innovations by the market players further extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Additionally, rising awareness about the benefits of sterile and antiviral packaging will further expand the future growth of the sterile and antiviral packaging market.

Restraints/Challenges

• Strict Regulatory Standards

The sterile and antiviral packaging processes is manufactured to basically ensure the sterility of packaged goods up until the time of use. As a result, manufacturing of them is subject to severe regulatory restrictions. These requirements guarantee that the sealed devices or instruments won't be adversely affected by, or damaged by, external factors or packaging. The international standard governing sterilized medical devices or instruments' warranty obligations is EN ISO 11607. Different packaging goods, including material selection, design qualification, design testing and control, and process validation, apply these validation needs. The criteria are complicated and serve as a market restraint over the forecast period

• High Costs

Despite advances in medical technology, many customers are still unable to afford the rising costs of global healthcare and are therefore calling for more affordable goods. Over the forecast period, rising plastic waste output is projected to restrain the market for sterile and antiviral packaging. Therefore, this will challenge the sterile and antiviral packaging market growth rate.

This sterile and antiviral packaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the sterile and antiviral packaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Sterile and Antiviral Packaging Market

The recent outbreak of coronavirus had a significant influence on the sterile and antiviral packaging market. Increased customer concern about the virus' potential to persist on package surfaces would be the immediate result. This would stimulate demand for sterile and antiviral packaging due to its antiviral and antibacterial capabilities. Pharmaceutical and biotech companies are collaborating with governments from all over the world to combat the COVID-19 outbreak, from promoting the development of vaccinations to addressing issues with the distribution of medications. There are now 155 compounds and about 115 vaccine candidates in the research and development (R&D) pipeline. Additionally, commonly used medications like hydroxychloroquine have seen an unexpected increase in demand for the treatment of COVID-19. Due to the severe lack of these medications in many developed countries, the strong demand has created enormous opportunities for COVID-19 management drug makers. As a result, the need for COVID-19 vaccines and medications to treat the disease is expected to propel the pharmaceutical and biotechnology industries forward.

Following the epidemic, consumers would likely be more aware of and concerned about certain food goods and packaging, likely affecting their decisions. The demand for sterile and antiviral packaging is projected to increase exponentially as consumer sentiment toward consumption is predicted to become increasingly concerned with safety and contamination hazards.

Recent Development

• In November 2021, Becton, Dickinson and Company constructed a new manufacturing plant in Zaragoza, Spain to facilitate the expansion of pre-filled syringes in the area. The new facility will incorporate the most recent in intelligent and autonomous technologies, often known as Industry 4.0 solutions, and it will be a fully digital site that complies with stringent sustainability and eco-efficiency criteria.

Global Sterile and Antiviral Packaging Market Scope

The sterile and antiviral packaging market is segmented on the basis of packaging type, material type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Packaging Type

• Vials and Ampoules
• Blister and Clamshells

 Material Type

• Plastics
• Glass
• Metal
• Paper and Paperboard

 End-User

• Surgical and Medical Instruments
• Pharmaceuticals and Biological

Sterile and Antiviral Packaging Market Regional Analysis/Insights

The sterile and antiviral packaging market is analyzed and market size insights and trends are provided by country, packaging type, material type and end-user as referenced above.

The countries covered in the sterile and antiviral packaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the sterile and antiviral packaging market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period of 2022-2029. The market growth over this region is attributed to the significant share of stakeholder’s investments, research and development within the region.

Asia-Pacific on the other hand, is estimated to show lucrative growth over the forecast period of 2022-2029, due to the favorable government policies as well as the evolution of medical science and increased life expectancy in the region.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Sterile and Antiviral Packaging Market Share Analysis

The sterile and antiviral packaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to sterile and antiviral packaging market.

Some of the major players operating in the sterile and antiviral packaging market are

• 3M (U.S.)
• Anchor Packaging LLC, (U.S.)
• Berry Global Inc., (U.S.)
• CeDo Ltd., (U.K.)
• Dow., (U.S.)
• Harwal Group of Companies, (UAE)
• Intertape Polymer Group, (Canada)
• Jindal Poly, (India)
• Klöckner Pentaplast, (Germany)
• Mitsubishi Chemical Corporation, (Japan)
• Multi Wrap (Pty) Ltd. (South Africa)
• Schott (Germany)
• Amcor plc (Switzerland)
• AptarGroup, Inc., (U.S.)
• Klöckner Pentaplast (Germany)
• West Pharmaceutical Services, Inc. (U.S.)
• Berry Global Inc. (U.S.)
• Honeywell International, Inc. (U.S.)
• ACG (India), Nipro (Japan)
• Gerresheimer AG (Germany)
• Catalent Inc., (U.S.),
• WestRock Company (U.S.)
• Nan Ya Plastics Corporation (China)